MAP3K6 and breast cancer: Hypermethylation of CYFIP1 gene (only CpGDM hypermethylated in patients) was observed in patients with breast cancer (P = 2.22 × 10−12), while MAP3K6 and MIB2 gene promoters showed a slight hypomethylation in BCP (Fig. S2).